VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BMRN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BMRNBioMarin Pharmaceutical Inc.
$60.35$11.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBMRNQuarterly Cash Flow

BioMarin Pharmaceutical Inc. (BMRN) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

BioMarin Pharmaceutical Inc. (BMRN) quarterly cash flow statement — complete operating, investing & financing history

BMRN Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations220.65M99.64M368.69M185.27M174.39M185.63M221.48M118.76M46.97M27.48M135.65M70.06M-73.93M6.79M158.32M56.23M-45.43M11.18M97.06M82.78M
Operating CF Margin %28.8%11.39%47.5%22.45%23.4%24.84%29.7%16.68%7.24%4.25%23.33%11.77%-12.4%1.26%31.33%10.53%-8.75%2.49%23.75%16.5%
Operating CF Growth %26.52%-46.32%66.46%56%271.28%575.42%63.28%69.51%163.53%305%-14.32%24.61%-62.73%-39.3%63.12%-32.08%-140.02%183.53%12.59%198.46%
Net Income105.53M139.11M-30.74M426.22M185.69M124.94M106.08M107.17M88.66M20.38M40.38M56.04M50.85M-249K-6.65M27.66M120.8M-57.9M-36.49M12.94M
Depreciation & Amortization16.41M20.44M18.49M18.56M22.07M23.61M19.01M26.46M27.35M26.86M25.68M25.42M26.42M24.55M24.8M25.27M27.34M25.99M26.84M27.22M
Stock-Based Compensation43.46M46.91M49.27M47.53M37.7M51.92M43.49M47.91M58.25M54.85M48.39M50.16M53.7M46.73M54.66M47.08M47.83M43.89M49.03M0
Deferred Taxes9.22M613K-13.65M33.34M28.43M42.39M12.17M1.25M285K-24.84M-15.03M1.25M-6.36M-51.34M-4.2M-1.34M4.8M-3.59M-13.22M-2.13M
Other Non-Cash Items6.97M-128.36M226.4M-182.31M-9.03M25.92M1.67M2.88M-22.19M47.35M-3.69M-111K18.1M236K-1.82M-4.37M-109.51M2.9M2.92M54.88M
Working Capital Changes39.07M20.93M118.93M-158.07M-90.46M-83.15M39.06M-66.92M-105.39M-97.12M39.92M-62.7M-216.64M-13.14M91.53M-38.07M-136.69M-116K68M-10.12M
Change in Receivables-7.16M-120.68M48.75M-98.53M-57.59M72.55M-74.38M-52.7M-3.39M-58.49M13.89M-7.04M-138.8M-28.28M38.81M-37.75M-54.81M61K48.09M-22.87M
Change in Inventory44.49M218M-26.33M-48.13M-24.34M-34.27M18.15M-30.59M-16.82M-59.11M-41.47M-42.38M-14.1M-40.84M-25.99M-2.56M1.13M-15.94M-25.5M12.8M
Change in Payables3.1M-53.34M116.37M5.77M-2.65M-100.26M122.28M4.75M-59.01M12.52M81.43M6.59M-31.69M61.42M73.95M1.8M-78.14M053.76M11.42M
Cash from Investing725.53M-42.45M-330.96M-12.59M-28.24M76.4M-16.16M90.48M-14.24M-64.96M-45.8M29.53M-30.01M-54.71M-23.4M-29.7M87.78M-55.42M-119.85M-120.26M
Capital Expenditures-20.92M-40.72M-33.75M-17.1M-16.77M-19.53M-18.46M-21.33M-26.1M-36.7M-23.42M-21.58M-24.46M-35.69M-29.3M-27.15M-28.82M-28.74M-18.73M-26.25M
CapEx % of Revenue2.73%4.66%4.35%2.07%2.25%2.61%2.48%3%4.02%5.68%4.03%3.63%4.1%6.64%5.8%5.09%5.55%6.39%4.58%5.23%
Acquisitions00-285.19M000000024.06M000000000
Investments--------------------
Other Investing4.97M-2.37M0-266K0-769K-1.57M-512K2M0-24.06M-1.15M-310K-7.35M-7.17M-881K108.14M-15.62M-1.71M-908K
Cash from Financing813.17M3.16M-2.17M-4.6M-38.78M2.86M-499.13M12.61M-42.79M10.84M-788K11.96M-40.74M10.87M7.54M-11.78M-25.28M14.4M-1.03M10.95M
Debt Issued (Net)841.35M00000-494.93M-18K-42K-45K-606K-621K-1.01M-970K-513K-556K-566K-547K-551K-857K
Equity Issued (Net)0-31.07M7K7.71M-38.78M000014.8M4.36M0000000021.82M
Dividends Paid00000000000000000000
Share Repurchases0-38.78M00-38.78M000000000000000
Other Financing-28.18M34.23M-2.18M-12.31M02.86M-4.2M12.63M-42.75M-3.92M-4.54M12.58M-39.73M11.84M8.05M-11.22M-24.71M14.94M-480K-10.02M
Net Change in Cash1.76B61.57M36.29M165.01M105.96M267.39M-296.7M225.15M-8.13M-30.29M91.03M114.31M-144.46M-36.98M141.71M14.36M18.16M-29.87M-24.39M-25.78M
Free Cash Flow199.73M58.92M340.24M168.17M157.63M165.33M200.31M96.92M12.87M-9.21M112.23M47.33M-98.7M-29.57M121.85M28.19M-76.11M-33.18M76.7M60.19M
FCF Margin %26.07%6.74%43.84%20.37%21.15%22.12%26.86%13.61%1.98%-1.43%19.31%7.95%-16.55%-5.5%24.11%5.28%-14.65%-7.38%18.76%12%
FCF Growth %26.71%-64.36%69.86%73.51%1125.04%1894.51%78.48%104.77%113.04%68.85%-7.9%67.9%-29.68%10.87%58.87%-53.16%-189.27%25.29%10.14%1147.06%
FCF per Share1.010.301.770.860.800.841.020.480.06-0.050.590.24-0.51-0.160.660.15-0.39-0.180.420.32
FCF Conversion (FCF/Net Income)2.09x-2.14x-11.99x0.77x0.94x1.49x2.09x1.11x0.53x1.35x3.36x1.25x-1.45x-27.25x-23.80x2.03x-0.38x-0.19x-2.66x6.40x
Interest Paid00-65K3.64M03.71M1.53M3.71M1.42M3.66M1.47M3.74M1.44M3.71M1.44M3.71M1.42M3.72M1.48M0
Taxes Paid007.82M52M10.39M21.18M13.2M20.58M2.3M21.63M23.5M23.82M4.36M40.95M1.6M10.51M1.32M2.62M5.37M0